Product Information |
DR-XY43830_PI_01.pdf
|
Registration Number |
DR-XY43830
|
Generic Name |
Canagliflozin
|
Brand Name |
Invokana
|
Dosage Strength |
100 mg
|
Dosage Form |
Film-Coated Tablet
|
Classification |
Prescription Drug (RX)
|
Packaging |
Alu/PVC blister pack x 10's
(Box of 3 blister packs x 10 tablets); Alu/PVC blister pack x 5's (Box of 1 blister pack x 5 tablets)
|
Pharmacologic Category |
Sodium-glucose co-transporter 2 (SGLT2) Inhibitor
|
Manufacturer |
Janssen Cilag S.P.A.
|
Country of Origin |
Italy
|
Trader |
|
Importer |
Johnson & Johnson (Philippines), Inc.
|
Distributor |
Johnson & Johnson (Philippines), Inc.
|
Application Type |
Initial (from Monitored Release)
|
Issuance Date |
16 June 2022
|
Expiry Date |
23 October 2024
|